---
category: news
title: "BioXcel Therapeutics Announces $260 Million Strategic Financing with Oaktree and Qatar Investment Authority"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (the “Company” or “BioXcel Therapeutics”), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2022-04-19T11:13:00Z
originalUrl: "https://www.tmcnet.com/usubmit/2022/04/19/9584691.htm"
webUrl: "https://www.tmcnet.com/usubmit/2022/04/19/9584691.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "CKnITODETMknI/sDDjV7R2VTcslWcTCYkgP4IxTg/zSZ2PgqAWUuc4WWHI8WS3aczLTtIU618nGQlXB7on4XTC14eazK2C3w9SxDuq3tbh+xzbgt0dxNn5w1qARMmpISxl+MvP31F5dbwGtNQpWDF9XBjLMF09aHVkGyBx3neI2ASc1QrVxO0APbOlUXujvMDTQ3/IwOkg9eWrdgGBJ5f1bM23Btwc1qSQEhBZVeY7fUuutex0B5YDXcAqmxJd5bxDC3Fs5jbeg2RZzJ9Dx+K2jXcet9ypvrg1tmMyYAykdLBZOrwF0KM0wEewB/dDoyQ1SNhIFZ3TAkgnB8bCXpC8L+6CJzqr5c8Eq/uPFHK5w=;xlr5Tz/66O0aAzqZRvwheQ=="
---

